BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 45 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,229 | -90.3% | 16,138 | 0.0% | 0.00% | – |
Q2 2023 | $33,244 | -28.0% | 16,138 | +15.3% | 0.00% | – |
Q1 2023 | $46,174 | +9.6% | 13,992 | -45.5% | 0.00% | – |
Q4 2022 | $42,117 | -69.0% | 25,681 | -16.3% | 0.00% | – |
Q3 2022 | $136,000 | -17.1% | 30,681 | -15.3% | 0.00% | – |
Q4 2020 | $164,000 | -62.7% | 36,202 | +39.2% | 0.00% | -100.0% |
Q3 2020 | $440,000 | +26.4% | 26,002 | -16.1% | 0.00% | 0.0% |
Q2 2020 | $348,000 | +11500.0% | 31,002 | +3000.2% | 0.00% | – |
Q4 2016 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2015 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $4,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EAM Investors, LLC | 129,929 | $603,000 | 0.19% |
ABNER HERRMAN & BROCK LLC | 56,050 | $260,000 | 0.06% |
CFO4Life Group, LLC | 12,000 | $56,000 | 0.03% |
Spark Investment Management LLC | 12,000 | $55,000 | 0.03% |
Phoenix Holdings Ltd. | 118,533 | $534,000 | 0.03% |
HighPoint Advisor Group LLC | 13,533 | $82,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 12,500 | $58,000 | 0.02% |
ETF MANAGERS GROUP, LLC | 66,197 | $299,000 | 0.01% |
WINTON GROUP Ltd | 76,967 | $357,000 | 0.01% |
IHT Wealth Management, LLC | 13,000 | $60,000 | 0.01% |